What's new

Human medicines European public assessment report (EPAR): Koselugo, selumetinib, Date of authorisation: 17/06/2021, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Koselugo, selumetinib, Date of authorisation: 17/06/2021, Revision: 6, Status: Authorised

Mar 14, 2025 - 15:07
 0
Human medicines European public assessment report (EPAR): Koselugo, selumetinib, Date of authorisation: 17/06/2021, Revision: 6, Status: Authorised
Human medicines European public assessment report (EPAR): Koselugo, selumetinib, Date of authorisation: 17/06/2021, Revision: 6, Status: Authorised
Read More

Tags:

Previous Article

Veterinary medicines European public assessment report (EPAR): Mhyosphere PCV ID...

Next Article

Spontaneous Passivation of Selective Zn (101) Plating via Dangling Bond Saturati...

Related Posts

Clinical investigation of medicinal products in the treatment of epileptic disorders - Scientific guideline

Clinical investigation of medicinal products in the tre...

Mar 12, 2025  0

Combination of cystic fibrosis medicines to treat patients with rare mutations

Combination of cystic fibrosis medicines to treat patie...

Feb 28, 2025  0

Orphan designation: Ex-vivo-expanded autologous human corneal epithelium-containing stem cells Corneal lesions, with associated corneal (limbal) stem cell deficiency, due to ocular burns, 07/11/2008 Expired

Orphan designation: Ex-vivo-expanded autologous human c...

Mar 7, 2025  0